Mark Genovese, MD, professor of immunology and rheumatology and the study’s lead author a Stanford University School of Medicine investigator, a novel drug for rheumatoid arthritis substantially reduced symptoms and improved daily physical functioning in patients for whom other therapies had failed. Photo taken at his office at Stanford on Monday, March 28, 2016. ( Norbert von der Groeben/ Stanford School of Medicine )